Skip to main content

RITHOLTZ WEALTH MANAGEMENT

Position in ABBV — AbbVie Inc.

CIK 1698218 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$12,452,908
+$2,027,525 QoQ
Shares Held
49,487
+3.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#806
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Mar 31, 2021
CallValue
$7,000
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RITHOLTZ WEALTH MANAGEMENT holds $147,518,356 across 14 Drug Manufacturers - General names. ABBV ranks #5 (8.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ABBV
AbbVie Inc.
This page
49,487 $12,452,908

All Filings in ABBV

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,452,908 49,487
2026-03-31 $10,425,383 47,935
2025-12-31 $10,841,393 47,448
2025-09-30 $10,124,086 43,725
2025-06-30 $7,724,019 41,612
2025-03-31 $8,325,277 39,735
2024-12-31 $6,806,265 38,302
2024-09-30 $7,515,496 38,057
2024-06-30 $6,665,438 38,861
2024-03-31 $7,136,134 39,188
2023-12-31 $5,636,413 36,371
2023-09-30 $6,015,614 40,357
2023-06-30 $4,655,864 34,557
2023-03-31 $6,720,473 42,169
2022-12-31 $6,554,739 40,559
2022-09-30 $6,874,101 51,219
2022-06-30 $5,824,062 38,026
2022-03-31 $7,269,822 44,845
2021-12-31 $1,600,969 11,824
2021-09-30 $1,050,761 9,741
2021-06-30 $1,120,317 9,946
2021-03-31 $1,053,088 9,731
2021-03-31 $7,000 400
2020-12-31 $7,000 500
2020-12-31 $767,836 7,166
2020-09-30 $423,585 4,836
2020-06-30 $393,309 4,006